Becton, Dickinson and Company (0R19.L)
USD 200.08
(-0.29%)
USD 200.08
(-0.29%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 6.71 Billion USD | 12.52% |
| 2022 | 5.96 Billion USD | -0.55% |
| 2021 | 5.99 Billion USD | 14.82% |
| 2020 | 5.22 Billion USD | 0.67% |
| 2019 | 5.18 Billion USD | 3.37% |
| 2018 | 5.02 Billion USD | 33.05% |
| 2017 | 3.77 Billion USD | -1.57% |
| 2016 | 3.83 Billion USD | -1.77% |
| 2015 | 3.9 Billion USD | 45.06% |
| 2014 | 2.69 Billion USD | -7.5% |
| 2013 | 2.9 Billion USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 1.51 Billion USD | 24.61% |
| 2024 Q3 | 1.7 Billion USD | 16.07% |
| 2024 Q2 | 1.46 Billion USD | -2.97% |
| 2023 Q3 | 1.48 Billion USD | -4.08% |
| 2023 Q2 | 1.54 Billion USD | 2.86% |
| 2023 FY | 5.97 Billion USD | 0.15% |
| 2023 Q1 | 1.5 Billion USD | -0.6% |
| 2023 Q4 | 1.21 Billion USD | -18.07% |
| 2022 FY | 5.96 Billion USD | -0.55% |
| 2022 Q4 | 1.51 Billion USD | 3.28% |
| 2022 Q3 | 1.46 Billion USD | -7.05% |
| 2022 Q2 | 1.57 Billion USD | 1.48% |
| 2022 Q1 | 1.55 Billion USD | -9.71% |
| 2021 Q1 | 1.49 Billion USD | -33.5% |
| 2021 Q3 | 1.58 Billion USD | -6.62% |
| 2021 FY | 5.99 Billion USD | 14.82% |
| 2021 Q4 | 1.71 Billion USD | 8.73% |
| 2021 Q2 | 1.69 Billion USD | 13.4% |
| 2020 Q3 | 1.27 Billion USD | -21.96% |
| 2020 Q4 | 2.24 Billion USD | 75.53% |
| 2020 FY | 5.22 Billion USD | 0.67% |
| 2020 Q2 | 1.63 Billion USD | 13.19% |
| 2020 Q1 | 1.44 Billion USD | -32.05% |
| 2019 Q2 | 1.81 Billion USD | 67.1% |
| 2019 FY | 5.18 Billion USD | 3.37% |
| 2019 Q4 | 2.13 Billion USD | 45.96% |
| 2019 Q3 | 1.46 Billion USD | -19.69% |
| 2019 Q1 | 1.08 Billion USD | -30.52% |
| 2018 FY | 5.02 Billion USD | 33.05% |
| 2018 Q4 | 1.56 Billion USD | 25.18% |
| 2018 Q3 | 1.25 Billion USD | -32.05% |
| 2018 Q2 | 1.84 Billion USD | 38.01% |
| 2018 Q1 | 1.33 Billion USD | 19.75% |
| 2017 Q4 | 1.11 Billion USD | -36.09% |
| 2017 FY | 3.77 Billion USD | -1.57% |
| 2017 Q1 | 671 Million USD | -54.17% |
| 2017 Q2 | 993 Million USD | 47.99% |
| 2017 Q3 | 1.74 Billion USD | 75.53% |
| 2016 Q2 | 1.01 Billion USD | -3.81% |
| 2016 Q3 | 1.03 Billion USD | 2.18% |
| 2016 Q1 | 1.05 Billion USD | -8.45% |
| 2016 Q4 | 1.46 Billion USD | 41.72% |
| 2016 FY | 3.83 Billion USD | -1.77% |
| 2015 Q2 | 738 Million USD | 6.49% |
| 2015 Q1 | 693 Million USD | -1.56% |
| 2015 FY | 3.9 Billion USD | 45.06% |
| 2015 Q4 | 1.14 Billion USD | -12.57% |
| 2015 Q3 | 1.31 Billion USD | 77.91% |
| 2014 Q3 | 667 Million USD | 0.0% |
| 2014 Q2 | 667 Million USD | 1.68% |
| 2014 Q1 | 656 Million USD | -34.92% |
| 2014 FY | 2.69 Billion USD | -7.5% |
| 2014 Q4 | 704 Million USD | 5.55% |
| 2013 Q2 | 635 Million USD | 3.42% |
| 2013 Q1 | 614 Million USD | 0.0% |
| 2013 Q4 | 1 Billion USD | 54.6% |
| 2013 FY | 2.9 Billion USD | 0.0% |
| 2013 Q3 | 652 Million USD | 2.68% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Phreesia, Inc. | 369.84 Million USD | -1714.834% |
| Accuray Incorporated | 142.61 Million USD | -4606.311% |
| Align Technology, Inc. | 2.07 Billion USD | -223.186% |
| Elevance Health Inc. | 36.23 Billion USD | 81.477% |
| AxoGen, Inc. | 149.33 Million USD | -4394.563% |
| Boston Scientific Corporation | 7.5 Billion USD | 10.578% |
| CVS Health Corporation | 40.68 Billion USD | 83.504% |
| Cardinal Health, Inc. | 5 Billion USD | -34.24% |
| Centene Corporation | 138.33 Billion USD | 95.148% |
| DaVita Inc. | 1.47 Billion USD | -355.365% |
| HCA Healthcare, Inc. | 45.43 Billion USD | 85.229% |
| Hologic, Inc. | 1.26 Billion USD | -429.505% |
| Humana Inc. | 102.36 Billion USD | 93.443% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | -514.178% |
| Laboratory Corporation of America Holdings | 2.02 Billion USD | -232.047% |
| Masimo Corporation | 867 Million USD | -674.164% |
| McKesson Corporation | 8.67 Billion USD | 22.628% |
| Patterson Companies, Inc. | 1.12 Billion USD | -495.395% |
| Quest Diagnostics Incorporated | 1.61 Billion USD | -316.894% |
| ResMed Inc. | 1.36 Billion USD | -390.51% |
| Henry Schein, Inc. | 2.93 Billion USD | -128.533% |
| Teladoc Health, Inc. | 2.09 Billion USD | -221.004% |
| Universal Health Services, Inc. | 9.2 Billion USD | 27.11% |
| Veeva Systems Inc. | 1.25 Billion USD | -433.949% |
| Baxter International Inc. | 5.27 Billion USD | -27.314% |
| Intuitive Surgical, Inc. | 2.96 Billion USD | -126.55% |
| Danaher Corporation | 8.75 Billion USD | 23.335% |
| Stryker Corporation | 9.2 Billion USD | 27.115% |
| Medtronic plc | 16.12 Billion USD | 58.386% |